Meng Li

Meng Li

Director Ejecutivo en CHANGE AGENTS CORPORATION .

Fortuna: 6 592 $ al 31/07/2026

48 años
Commercial Services
Health Services
Health Technology

Perfil

Meng Li is currently Chief Operating Officer, Secretary & Director at GenExosome Technologies, Inc. Ms. Li is Secretary, Chief Executive & Operating Officer at Avalon GloboCare Corp.
since 2025.
Ms. Li is President & Chief Operating Officer at Avalon (Shanghai) Healthcare Technology Co. Ltd. since 2019.
Formerly, Ms. Li was Managing Director at Group M Worldwide, Inc. from 2006 to 2015.
Ms. Li was Chief Operating Officer, Secretary & Director at Avalon Health Care, Inc. Ms. Li was Senior Manager at Zenith Media from 2000 to 2006.
Ms. Li completed undergraduate studies at Dalian Maritime University.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
29/06/2026 34.334 ( 0,24 % ) 6 592 $ 31/07/2026

Cargos activos de Meng Li

EmpresasCargoInicio
CHANGE AGENTS CORPORATION Director Ejecutivo 30/11/2025
Director de Operaciones -
Presidente 30/11/2019

Antiguos cargos conocidos de Meng Li.

EmpresasCargoFin
Corporate Officer/Principal 01/01/2015
Corporate Officer/Principal 01/01/2006
Director de Operaciones -
Ver el detalle de la experiencia de Meng Li.

Formación de Meng Li.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

23

Relaciones de 1er grado

7

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas7

Health Technology

Commercial Services

Commercial Services

Consumer Services

Health Services

Health Services

Miscellaneous